Gyre Therapeutics Inc. (GYRE) Financial Ratios & Valuation Metrics Analysis - P/E, ROE, Debt Ratios & Profitability - Stocknear
Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Start Trial

    Gyre Therapeutics Inc.

    NASDAQ: GYRE · Real-Time Price · USD
    7.16
    -0.13 (-1.78%)
    At close: Sep 26, 2025, 3:59 PM
    7.50
    4.75%
    After-hours: Sep 26, 2025, 05:47 PM EDT

    Gyre Therapeutics Ratios and Metrics

    Financials in USD. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
    Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
    PE Ratio
    		 85.20 -16.85 265.01 -4.76
    PEG Ratio
    		 -0.78 0.00 -2.62 2.32
    PS Ratio
    		 9.74 13.80 5.96 57.00
    PB Ratio
    		 16.26 -98.95 14.35 10.18
    P/FCF Ratio
    		 -172.88 90.50 -16.01 -4.94
    P/OCF Ratio
    		 -282.79 60.49 -18.43 -4.99
    OCF/S Ratio
    		 -0.03 0.23 -0.32 -11.41
    Debt / Equity Ratio
    		 0.03 -0.03 0.01 0.06
    Quick Ratio
    		 2.99 2.64 3.56 3.63
    Current Ratio
    		 3.32 2.85 4.06 3.63
    Asset Turnover
    		 0.84 0.97 1.21 0.13
    Interest Coverage
    		 n/a n/a n/a n/a
    Return on Equity
    		 0.19 5.87 0.05 -2.14
    Return on Assets
    		 0.10 -0.8 0.03 -1.58
    Return on Invested Capital
    		 0.12 -0.77 0.11 -2
    Dividend Yield
    		 n/a 0.15 0.07 n/a
    Payout Ratio
    		 n/a -2.55 19.56 n/a
    Gross Profit Margin
    		 0.96 0.96 0.95 -0.01
    Net Profit Margin
    		 0.11 -0.82 0.02 -11.98
    Pretax Profit Margin
    		 0.22 -0.68 0.09 -11.98
    Operating Profit Margin
    		 0.15 -0.59 0.09 -11.98
    FCF Margin
    		 -0.06 0.15 -0.37 -11.53
    EBITDA Margin
    		 0.17 0.18 0.10 -11.94

    Add to Watchlist